Why we don't put blue light in our red light therapy panels
In short
Blue light has its place for niche antimicrobial applications (in particular it's been researched for acne), but it also disrupts sleep and can damage skin so it is not suitable for use within red light therapy panels.
That's why HeroMask Elite™ has an optional 415nm "Acne Hero" mode, but our panels don't.
Key takeaways
- The acne evidence for blue light is specific: 405-420nm, held at the face, at a meaningful dose - and even then the pooled trials are not conclusive.Read this section: Where blue light may help
- Panels that add blue use a different colour (466-480nm) at a trace output, roughly a thirtieth of the dose that failed in a full-body blue light trial.Read this section: The blue in those panels is a different colour, and a trace of it
- 480nm is the peak of melanopsin sensitivity, about 24,000 times stronger than 660nm red at telling your brain it is daytime, so an evening session with blue in it works against sleep.Read this section: 480nm is the one wavelength your body clock is tuned to
- Safety standards weight blue at 450 times the retinal hazard of red, and 415nm has produced months-long pigmentation in olive and darker skin where red produced none.Read this section: What blue light does to your skin
- We keep panels red and near-infrared only, count only those wavelengths when comparing panels, and put 415nm in an opt-in mode on HeroMask Elite™.Read this section: What we do instead
A question we often get is "brand X's panel has seven wavelengths including blue - why don't yours?"
It is a fair question to ask.
The short version: Blue light has its place for niche antimicrobial applications, but it also disrupts sleep and can damage skin so it is not suitable for use within red light therapy panels.
Where blue light may help
Let's start with credit where it is due. Blue light is not useless. The bacteria involved in acne produce porphyrins that absorb light most strongly at about 405-420 nanometres, which is why acne devices use light in the 407-420nm range (Scott et al., 2019). The best known trial gave 107 people daily 15-minute sessions of 415nm blue plus 660nm red for 12 weeks and reported a 76% improvement in inflammatory spots (Papageorgiou et al., 2000).
That is exactly why our HeroMask Elite has an opt-in 415nm "Acne Hero" mode: close to the skin, at the wavelength the research used, with eye shields on, and switched off unless you want it. It's worth noting that when 14 acne trials were pooled, the overall effect was not statistically significant and most trials had a high risk of bias (Scott et al., 2019), and Cochrane rates the evidence for light therapies in acne as low certainty (Barbaric et al., 2016). Promising, targeted, not miraculous.
Notice what that evidence has in common. It is one indication (acne). It is one wavelength band (405-420nm). It is a device held at the face. And it is a meaningful dose. Now look at what the panels are doing.
The blue in those panels is a different colour, and a trace of it
The panels that add blue mostly use 480nm, not 415nm. The stated reason is that 480nm is "long wavelength blue" and therefore safer (source). There is a grain of truth in that for your skin and retina, which we'll come to. But it also means the blue in the panel is not the blue the acne research used. We could not find a single human acne trial at 470-480nm.
Then there is the amount. One of the most popular US panels describes its blue as "a trace amount at 2%" of the panel's output (source), and its own commissioned lab report lists "48 red, 50 infrared, and 2 blue" LEDs in the 100-LED model (lab report). The report measures the red band and the infrared band but no blue band at all. If you subtract red and infrared from the total, everything else comes to about 1.3 mW/cm² at 30cm (64.81 minus 26.84 minus 36.63 in their table), and that is a ceiling, not a measurement. Over a 15-minute session that is at most about 1.2 J/cm² of blue (1.34 mW/cm² × 900 seconds).
Compare that with the clinic acne protocols, which deliver around 40 J/cm² per session from a device 15cm from the face (Tzung et al., 2004, via Diogo et al., 2021; Morton et al., 2005). Even the most generous comparison, the portable 415nm lamp in the Papageorgiou trial, delivered about three times the panel's blue dose (4.23 mW/cm² for 15 minutes a day, about 3.8 J/cm²) at the bacteria's own wavelength, aimed at the face, every day for 12 weeks (Diogo et al., 2021). Or take the one rigorous full-body blue light trial, which gave 87 eczema patients 415nm or 450nm at 40 mW/cm² for 15 minutes (36 J/cm²), three times a week for eight weeks, against a sham. It did not improve a single objective skin score (Buhl et al., 2023; device parameters as reported in Sadowska et al., 2024). That is roughly 30 times the dose a 2% blue channel delivers, at the right wavelengths, and it still failed.
An independent reviewer who put a spectrometer on one of these panels found the blue peak at 466nm rather than 480nm, and on the newer model concluded it "behaves more like a five-wavelength device, as the blue and 1060 nm outputs are negligible" (Light Therapy Insiders, 2024; 2025). Adding blue may make for good marketing, but we haven't been able to find evidence to support its inclusion.
480nm is the one wavelength your body clock is tuned to
Here is the part that bothers us most. Your eyes contain a photoreceptor called melanopsin that tells your brain what time of day it is. It is most sensitive to light at about 480nm (Lucas et al., 2014; Brown et al., 2022). The international standard for measuring this (CIE S 026) puts 480nm at 97% of peak sensitivity, 630nm at 0.04% and 660nm at 0.004% (CIE S 026 dataset). Watt for watt, 480nm is roughly 24,000 times more powerful at telling your brain it is daytime than 660nm red is (our arithmetic from the CIE table: 0.966 divided by 0.0000407).
How much does it take? A consensus of sleep and circadian scientists recommends no more than 10 "melanopic lux" at the eye from three hours before bed (Brown et al., 2022). Run the numbers through the CIE standard and a bit over one microwatt per square centimetre of 480nm reaching an open eye is already at that limit (our arithmetic, using the standard's conversion constant of 1.3262 mW per melanopic lux: Schlangen & Price, 2021). A panel's blue channel is measured in milliwatts, a thousand times larger. In a lab study, 470nm blue at just 40 lux for 45 minutes suppressed melatonin; 630nm red at the same 40 lux did not (Figueiro et al., 2009). Even the brand adding the blue says it does "not recommend night-time light therapy treatment" (source).
Many of our customers use their panel in the evening as part of their wind-down routine. That only works because there is no blue in it. And notice the catch-22 in the "blue for alertness and mood" pitch: those effects happen through open eyes, which is exactly what your goggles cover.
What blue light does to your eyes
Blue light is a part of the visible spectrum that can damage the retina by a photochemical route rather than by heat. Safety standards weight each wavelength for this "blue light hazard": 415nm scores 0.80, 480nm scores 0.45, and every red wavelength from 600 to 700nm scores 0.001 (EU Directive 2006/25/EC, Annex I; ICNIRP, 2013). That gives blue 450 times the weighting of red (0.45 divided by 0.001). Cree, one of the biggest LED makers, classes its blue LED chips as Risk Group 2 at full current, and says red and green chips "do not pose as significant of an eye safety risk" (Cree LED). France's health and safety agency recommends that LED products sold to the public be Risk Group 0 or 1, and notes that children's eyes filter blue light less well (ANSES, 2019).
To be fair to the other side: 480nm is the least retina-hazardous shade of blue, and the strong evidence of harm comes from bright sources and lab studies, not from screens. But a panel at 30cm is not a screen and we have yet to find a panel brand that publishes a photobiological risk group for its blue channel.
What blue light does to your skin
Blue-violet light is a potent pigmenting wavelength for anyone with olive or darker skin. In a controlled study, 415nm produced a clear dose-dependent tan in skin types III and IV that was more pronounced than UVB and lasted up to three months; 630nm red produced none (Duteil et al., 2014). The sensor responsible has since been identified in melanocytes, and the long-lasting effect appears only in skin type III and above (Regazzetti et al., 2018). Blue light also produced oxidative stress in living skin where green, red and infrared did not (Nakashima et al., 2017). A panel lights your whole body, including all the skin you were not trying to treat. Generally speaking, blue light is best avoided for the skin.
Too weak to treat, too strong for the clock
Put it together and the blue diode ends up in a strange place. It delivers a fraction of an acne dose, at a wavelength no acne trial has used, spread across your whole body instead of aimed at a breakout. But if even one percent of it reaches your open eyes in the evening, it is over the circadian limit. It adds a retinal hazard class that red does not carry and a pigmentation risk that red does not carry, in exchange for a barely-studied wavelength addition.
What we do instead
Our panels are red and near-infrared only, and they will stay that way. Where blue has an evidence base - acne, at 415nm, close to the skin, eyes covered, earlier in the day - we put it in a dedicated mode on HeroMask Elite. When we compare panels, we count only the red and near-infrared wavelengths, because a wavelength count that includes blue is telling you about the marketing, not the therapy (see our comparison).
Two practical notes: First, we still ship goggles with every panel - to learn more about eye safety take a look at this blog post. Second, if you already own a panel with blue diodes, check whether the blue can be switched off (on some models it can).
If you have questions about any of this, get in touch - we'd love to help.
References
Our sources for this article along with direct links and the reason we chose to cite it.
- ANSES (2019). LEDs: ANSES's recommendations for limiting exposure to blue lightWhy we cite it: France's health and safety agency on blue light from LEDs: the basis for saying consumer LED products should be Risk Group 0 or 1, and that children's eyes filter blue light less well.
- Barbaric et al. (2016). Light therapies for acne. Cochrane Database of Systematic ReviewsWhy we cite it: The Cochrane review that rates the evidence for light therapies in acne as low certainty - the reason we call blue light for acne promising rather than proven.
- Brown et al. (2022). Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adults. PLOS BiologyWhy we cite it: The expert consensus recommending no more than 10 melanopic lux at the eye in the three hours before bed, and a source for melanopsin's peak sensitivity near 480nm.
- Buhl et al. (2023). Full-body blue light irradiation as treatment for atopic dermatitis: a randomized sham-controlled clinical trial (AD-Blue). JDDGWhy we cite it: The rigorous full-body blue light trial (415 or 450nm, 36 J/cm², three times a week for eight weeks, sham-controlled) that improved no objective skin score - roughly 30 times the dose a 2% blue channel delivers.
- CIE (2018). CIE S 026 alpha-opic action spectra datasetWhy we cite it: The international standard's action spectra, from which we take 480nm at 97% of melanopic sensitivity against 0.004% for 660nm - the basis of the 24,000-to-one figure.
- Cree LED. Eye safety with LED components (application note)Why we cite it: A major LED maker's own note classing its blue chips as Risk Group 2 at full current while red and green chips pose less of an eye-safety risk.
- Diogo et al. (2021). Effect of blue light on acne vulgaris: a systematic review. SensorsWhy we cite it: The systematic review we use for the dose figures: around 40 J/cm² a session in clinic acne protocols, and the output of the portable lamp in the Papageorgiou trial.
- Duteil et al. (2014). Differences in visible light-induced pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure. Pigment Cell and Melanoma ResearchWhy we cite it: The controlled study in which 415nm produced a dose-dependent tan lasting up to three months in skin types III and IV, while 630nm red produced none.
- European Parliament and Council (2006). Directive 2006/25/EC, Annex IWhy we cite it: The EU directive whose Annex I gives the blue light hazard weighting for each wavelength: 0.80 at 415nm, 0.45 at 480nm and 0.001 across red.
- Figueiro et al. (2009). Preliminary evidence that both blue and red light can induce alertness at night. BMC NeuroscienceWhy we cite it: The lab study in which 470nm blue at 40 lux for 45 minutes suppressed melatonin and 630nm red at the same 40 lux did not.
- ICNIRP (2013). Guidelines on limits of exposure to incoherent visible and infrared radiation. Health PhysicsWhy we cite it: The international exposure guidelines that use the same blue light hazard weighting as the EU directive.
- Light Therapy Insiders (2024, 2025). PlatinumLED BIOMAX 300 and BIOMAX PRO ULTRA reviewsWhy we cite it: Independent spectrometer measurements of a blue-equipped panel: the blue peak at 466nm rather than 480nm, and a newer model described as behaving like a five-wavelength device because its blue output is negligible.
- LightLab International. BIOMAX 300 intensity testing report (PDF)Why we cite it: The panel brand's own commissioned lab report, which lists 2 blue LEDs out of 100 and measures the red and infrared bands but no blue band - the basis of our 1.3 mW/cm² ceiling for the blue output.
- Lucas et al. (2014). Measuring and using light in the melanopsin age. Trends in NeurosciencesWhy we cite it: The reference paper on melanopsin and how to measure light for the non-visual system, including its peak sensitivity at about 480nm.
- Morton et al. (2005). An open study to determine the efficacy of blue light in the treatment of mild to moderate acne. Journal of Dermatological TreatmentWhy we cite it: A clinical acne study using blue light at the face; one of the two sources for the dose delivered in clinic protocols.
- Nakashima, Ohta and Wolf (2017). Blue light-induced oxidative stress in live skin. Free Radical Biology and MedicineWhy we cite it: The study in living skin where blue light produced oxidative stress and green, red and infrared did not.
- Papageorgiou, Katsambas and Chu (2000). Phototherapy with blue (415nm) and red (660nm) light in the treatment of acne vulgaris. British Journal of DermatologyWhy we cite it: The best-known acne trial: 415nm blue plus 660nm red, 15 minutes a day for 12 weeks, a 76% improvement in inflammatory spots. The strongest case for blue - and a face-held device at a real dose.
- PlatinumLED Therapy Lights. Myths about blue light therapy (brand blog post)Why we cite it: The brand's own explanation of why it adds 480nm and its advice against night-time use, quoted so the claims are in the brand's words rather than ours.
- PlatinumLED Therapy Lights. NIR+: the most advanced LED therapy light spectrum (brand blog post)Why we cite it: The source of the description of the panel's blue as a trace amount at 2% of output.
- Regazzetti et al. (2018). Melanocytes sense blue light and regulate pigmentation through opsin-3. Journal of Investigative DermatologyWhy we cite it: Identifies the blue-light sensor (opsin-3) in melanocytes and shows the long-lasting pigmentation response appears in skin type III and above.
- Sadowska et al. (2024). Prospective clinical study: full-body blue irradiation in the treatment of atopic dermatitis. Dermatology and TherapyWhy we cite it: Reports the device parameters of the full-body blue light trial, which we use to work out the dose it delivered.
- Schlangen and Price (2021). The lighting environment, its metrology, and non-visual responses. Frontiers in NeurologyWhy we cite it: Gives the conversion constant (1.3262 mW per melanopic lux) behind our estimate that about one microwatt per square centimetre of 480nm at the eye already reaches the evening limit.
- Scott et al. (2019). Blue-light therapy for acne vulgaris: a systematic review and meta-analysis. Annals of Family MedicineWhy we cite it: The meta-analysis of 14 acne trials: the porphyrin absorption peak at 405-420nm, and the finding that the pooled effect was not statistically significant, with a high risk of bias in most trials.
- Tzung, Wu and Huang (2004). Blue light phototherapy in the treatment of acne. Photodermatology, Photoimmunology and PhotomedicineWhy we cite it: A blue light acne trial whose dose, via the Diogo review, anchors the roughly 40 J/cm² clinic protocol figure.
Speak to us
Questions about this article, or about which device fits what you want to do? Email us or leave a comment. Advice is complimentary and there is no obligation to buy anything.
Disclaimer
Red Light Hero devices use clinical-grade LEDs but are not included in the ARTG and are not intended to treat or prevent disease. The research discussed here is about the wavelengths and technologies we use, not about our products. This article is educational information only, not medical advice - check with your healthcare professional before use, particularly if you are pregnant, take medication that increases light sensitivity, or have a condition affecting your eyes or skin.